Global Prescription Dermatology Therapeutics Market Report By Product Type (Acne & Rosacea Drugs, Psoriasis Drugs, Dermatitis & Seborrhea Drugs, Fungal Infection Drugs, Skin Cancer Drugs, And Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, And Mail Order Pharmacies) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2018-2025
ID:VMR11211184
August 2019
Report Formats:

The global demand for Prescription Dermatology Therapeutics Market is presumed to reach the valuation of nearly USD XX.X MN by 2025 from USD XX.X MN in 2018 with a CAGR of X.XX% under the study period of 2019- 2025.
 
Dermatology therapeutics refers to the branch of medicine that is concerned, specifically with the treatment of skin, hair, nails and mucous membranes. Dermatological disorders differ with geographic location, climatic conditions, socioeconomic status, lifestyles, age, gender, heredity, and personal habits.
 
Market Dynamics
 
The increasing incidence rate of chronic and infectious dermatological disorders across the globe are primarily driving the market growth. Rising adoption of biologics for the treatment of moderate to severe dermatological disorders, especially psoriasis is again accelerating the market growth. However, increasing stringent rules and regulation for approval of dermatology drugs is likely to hamper the market growth. Whereas, increasing awareness about dermatology solutions among patient in emerging economies is expected to drive the demand in upcoming years.
 
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
 
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of prescription dermatology therapeutics.
 
Market Segmentation
 
The entire prescription dermatology therapeutics market has been sub-categorized into product type and distribution channel. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
 
By Product Type

  • Acne & Rosacea Drugs
  • Psoriasis Drugs
  • Dermatitis & Seborrhea Drugs
  • Fungal Infection Drugs
  • Skin Cancer Drugs
  • Others
 
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Mail Order Pharmacies
 
Regional Analysis
 
This section covers regional segmentation which accentuates on current and future demand for prescription dermatology therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
 
Europe Prescription Dermatology Therapeutics Market By Revenue (USD MN)
 
Europe Prescription Dermatology Therapeutics Market By Revenue
 
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the prescription dermatology therapeutics market include AbbVie, Inc., Aclaris Therapeutics, Inc., Amgen, Inc., Aurobindo Pharma Ltd, Bausch Health Companies, Inc., Celgene Corporation, Eli Lilly and Company, Janssen Biotech, Inc., LEO Pharma A/S, Novartis AG, Pfizer, Inc. and Sun Pharmaceuticals Ltd. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
                                          
 
METHODOLOGY:
 
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
 
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1. INTRODUCTION

  • Introduction To Prescription Dermatology Therapeutics
  • Report Description
    • Objectives Of The Study
    • Assumptions
  • Research Scope
  • Research Methodology
    • Data Source
 
2. EXECUTIVE SUMMARY
  • Market Highlight
  • Global Prescription Dermatology Therapeutics Market: Snapshot
 
3. MARKET ANALYSIS
  • Drivers
  • Restraints
  • Opportunities
  • Porter’s Five Forces Analysis
  • Value Chain Analysis
 
4. PRESCRIPTION DERMATOLOGY THERAPEUTICS MARKET ANALYSIS BY PRODUCT TYPE
  • Market In Acne & Rosacea Drugs
  • Market In Psoriasis Drugs
  • Market In Dermatitis & Seborrhea Drugs
  • Market In Fungal Infection Drugs
  • Market In Skin Cancer Drugs
  • Market In Others
 
5. PRESCRIPTION DERMATOLOGY THERAPEUTICS MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  • Market In Hospital Pharmacies
  • Market In Retail Pharmacies
  • Market In Mail Order Pharmacies
 
6. PRESCRIPTION DERMATOLOGY THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY
  • North America (NA)
    • North America Market Estimates
    • North America Market Estimates By Country
    • United States (U.S.) Market Estimates By Segments
    • Rest Of North America Market Estimates By Segments
  • Europe (EU)
    • Europe Market Estimates
    • Europe Market Estimates By Country
    • United Kingdom (UK) Market Estimates By Segments
    • Germany Market Estimates By Segments
    • France Market Estimates By Segments
    • Rest Of Europe Market Estimates By Segments
  • Asia Pacific (APAC)
    • Asia Pacific Market Estimates
    • Asia Pacific Market Estimates By Country  
    • China Market Estimates By Segments
    • Japan Market Estimates By Segments
    • India Market Estimates By Segments
    • Rest Of Asia Pacific Market Estimates By Segments  
  • Latin America (LA)   
    • Latin America Market Estimates
    • Latin America Market Estimates By Country
    • Brazil Market Estimates By Segments
    • Rest Of Latin America Market Estimates By Segments
  • Middle East And Africa (MEA)   
    • Middle East And Africa Market Estimates
    • Middle East And Africa Market Estimates By Country
    • Middle East Market Estimates By Segments
    • Africa Market Estimates By Segments
 
7. COMPETITIVE LANDSCAPE OF THE PRESCRIPTION DERMATOLOGY THERAPEUTICS COMPANIES
  • Market Competition
  • Partnerships/Collaborations/Agreements
  • Mergers And Acquisitions
  • New Product Launches
  • Other Developments
 
8. COMPANY PROFILES OF THE PRESCRIPTION DERMATOLOGY THERAPEUTICS INDUSTRY (Company Overview, Financial, Major Products & Recent Development)
  • AbbVie, Inc.
  • Aclaris Therapeutics, Inc.
  • Amgen, Inc.
  • Aurobindo Pharma Ltd
  • Bausch Health Companies, Inc.
  • Celgene Corporation
  • Eli Lilly and Company
  • Janssen Biotech, Inc.
  • LEO Pharma A/S
  • Novartis AG
  • Pfizer, Inc.
  • Sun Pharmaceuticals Ltd.
 
* Tentative TOC
 
LIST OF TABLES
 
Table 1.  Market Highlights Of Prescription Dermatology Therapeutics
Table 2.  Global Prescription Dermatology Therapeutics Market By Product Types
Table 3.  Global Prescription Dermatology Therapeutics Market By Distribution Channel
Table 4.  Global Prescription Dermatology Therapeutics Market By Geography
Table 5.  North America Prescription Dermatology Therapeutics Market
Table 6.  Europe Prescription Dermatology Therapeutics Market
Table 7.  Asia Pacific Prescription Dermatology Therapeutics Market
Table 8.  Latin America Prescription Dermatology Therapeutics Market
Table 9.  Middle East And Africa Prescription Dermatology Therapeutics Market 
Table 10. Partnership/Collaboration/Agreements
Table 11. Mergers And Acquisitions
Table 12. New Product Development
Table 13. Other Developments
  
LIST OF FIGURES
 
Fig. 1.     Market Segmentation Of Prescription Dermatology Therapeutics Market 
Fig. 2.     Top-Down Approach   
Fig. 3.     Bottom-Up Approach   
Fig. 4.     Market Highlights Of Prescription Dermatology Therapeutics
Fig. 5.     Porter’s Five Forces Analysis
Fig. 6.     Value Chain Analysis
Fig. 7.     Global Prescription Dermatology Therapeutics Market By Product Types
Fig. 8.     Global Prescription Dermatology Therapeutics Market By Distribution Channel
Fig. 9.     Global Prescription Dermatology Therapeutics Market By Geography
Fig. 10.   North America Prescription Dermatology Therapeutics Market
Fig. 11.   Europe Prescription Dermatology Therapeutics Market
Fig. 12.   Asia Pacific Prescription Dermatology Therapeutics Market
Fig. 13.   Latin America Prescription Dermatology Therapeutics Market
Fig. 14.   Middle East And Africa Prescription Dermatology Therapeutics Market
Fig. 15.   Market Share Of Prescription Dermatology Therapeutics Companies
Fig. 16.   Recent Developments In Prescription Dermatology Therapeutics Industry
 
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC. 

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials